Rycarfa Tablets 50mg
Krka Uk
Rycarfa Tablets 50mg from KRKA UK LTD is supplied as a tablet.
LEGAL CLASSIFICATION:POM-V
THIS MEDICINE REQUIRES A PRESCRIPTION.
This can be uploaded on this page or it can be sent to mail@vets4u.uk.
We also require information about you and your Pet for us to be able to dispense your Pets medicine, please provide us with all your up to date information in the Question boxes below.
A link to the Medicine SPC on the VMD Product database can be found here: VMD Product Database
UK Public Assessment Report: UKPAR (PDF)
Post-Authorisation Assessment Report: PAAR (PDF)
Read the full Rycarfa product information ›
Active Ingredient(s)
Carprofen
Pack & Presentation
Form: Tablet · Pack size: PK 100
Suitable Species
Dogs
Owner Handling & Safety
In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician. Wash hands after handling the product.
Regulatory Information
- Legal category: POM-V
- Marketing authorisation holder: KRKA, d.d., Novo mesto Šmarješka cesta 6 8501 Novo mesto Slovenia Further information Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, nonsteroids. ATCvet code: QM01AE91 Carprofen possesses anti-inflammatory, analgesic and antipyretic activity. Like most other NSAID’s, carprofen is an inhibitor of the enzyme cyclo-oxygenase of the arachidonic acid cascade. However, the inhibition of prostaglandin synthesis by carprofen is slight in relation to its anti-inflammatory and analgesic potency. The precise mode of action of carprofen is not clear. Carprofen is a chiral drug with the S(+) enantiomer being more active than the R(-) enantiomer. There is no chiral inversion between the enantiomers in-vivo. Carprofen is well absorbed after oral administration (90%) and is highly protein bound. Peak plasma concentrations are achieved between 1 h and 3 h after administration. Carprofen is characterized by a half-life of approximately 10 hours in dogs. Carprofen is eliminated in dogs primarily by means of biotransformation in the liver, followed by rapid excretion of the resulting metabolites in faeces (70-80%) and urine (10-20%). Some enterohepatic circulation has been detected. Special precautions for the disposal of unused veterinary medicinal products or waste materials derived from the use of such products: Medicines should not be disposed of via wastewater. Use take-back schemes for the disposal of any unused veterinary medicinal product or waste materials derived thereof in accordance with local requirements and with any national collection systems applicable to the veterinary medicinal product concerned. List of Excipients: Ferric oxide red (E172), Ferric oxide black (E172), Lactose monohydrate, Maize starch, Povidone K30, Sodium starch glycolate -type A, Colloidal anhydrous silica, Meat flavour 10022, Talc, Magnesium stearate
- MA number: Rycarfa 20mg Tablets for Dogs Vm 01656/4069 Rycarfa 50mg Tablets for Dogs Vm 01656/4070 Rycarfa 100mg Tablets for Dogs Vm01656/4071
Product Information
LEGAL CLASSIFICATION: POM-V
THIS MEDICINE REQUIRES A PRESCRIPTION.
This can be uploaded on this page or it can be sent to .We also require information about you and your Pet for us to be able to dispense your Pets medicine, please provide us with all your up to date information in our short questionnaire above on form link found HERE.
PRESENTATION
USES
Link to Data Sheet: Summary of Product Characteristics
Important Notice
The information on this page is provided for general guidance only and does not replace the advice of a qualified veterinary surgeon. Always follow the directions provided on the product packaging and by your veterinary practice. If your animal's condition does not improve, worsens, or any side effects occur, contact your veterinary surgeon immediately.
